Open Access
CC BY-NC-ND 4.0 · Endoscopy 2023; 55(S 01): E360-E361
DOI: 10.1055/a-1996-0558
E-Videos

Direct compression hemostasis using a balloon dilator for bleeding after esophageal stent placement

1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Kazuya Hosotani
2   Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan
,
Hiroyuki Ono
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
› Author Affiliations
 

The European Society of Gastrointestinal Endoscopy guidelines recommend the placement of self-expandable metal stents (SEMSs) for palliation of malignant dysphagia over other treatments [1]. Although esophageal stenting enables maintenance of oral intake and improved quality of life, it carries the risk of life-threatening adverse events such as bleeding [2] [3]. Herein, we report a case in which hemostasis was achieved using an endoscopic balloon dilator for massive bleeding after esophageal SEMS placement.

An 80-year-old man presented with dysphagia caused by advanced esophageal cancer of the middle thoracic esophagus. He did not desire active treatment such as surgery or chemoradiotherapy; he instead underwent placement of a fully covered SEMS (Niti-S Stent 18 × 80 mm; Taewoong Medical, Seoul, Korea) ([Fig. 1]). Dysphagia was alleviated and oral dietary intake improved after SEMS placement.

Zoom
Fig. 1 A fully covered self-expandable metal stent (Niti-S Stent 18 × 80 mm; Taewoong Medical, Seoul, Korea) was placed for malignant esophageal stenosis caused by advanced esophageal cancer.

Massive hematemesis occurred 4 months after SEMS placement. Urgent endoscopy revealed massive bleeding with coagulum in the esophagus. We diagnosed bleeding from the SEMS placement site and removed the SEMS by pulling back the proximal lasso using grasping forceps. Following SEMS removal, securement of the visual field and identification of the bleeding point were difficult because of massive bleeding ([Fig. 2]). Therefore, we attempted to perform hemostasis by direct compression using an endoscopic balloon dilator (EZDilate, 18–20 mm; Olympus Medical, Tokyo, Japan) ([Video 1]). The balloon dilator was inflated to a pressure of 3 atm, and 3–5 minutes of direct compression hemostasis was repeated until hemostasis was confirmed ([Fig. 3]). Complete hemostasis was achieved after three sessions of direct compression hemostasis ([Fig. 4]).

Zoom
Fig. 2 Endoscopic images of esophageal bleeding after stent removal. Securement of the visual field and identification of the bleeding point were difficult due to the massive bleeding.

Video 1 Direct compression hemostasis using an endoscopic balloon dilator for bleeding after esophageal stent placement.

Zoom
Fig. 3 The balloon dilator was inflated to a pressure of 3 atm, and 3–5 minutes of direct compression hemostasis was repeated until confirmation of hemostasis.
Zoom
Fig. 4 Complete hemostasis was achieved after three session of direct compression hemostasis.

Endoscopy performed 2 days after hemostasis confirmed the absence of bleeding or perforation at the tumor site. No rebleeding occurred after hemostasis.

Endoscopy_UCTN_Code_CPL_1AH_2AD

Endoscopy E-Videos is an open access online section, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high quality video and all contributions are freely accessible online. Processing charges apply (currently EUR 375), discounts and wavers acc. to HINARI are available.

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos


Competing interests

The authors declare that they have no conflict of interest.

  • References

  • 1 Spaander MCW, van der Bogt RD, Baron TH. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021. Endoscopy 2021; 53: 751-762
  • 2 Didden P, Reijm AN, Erler NS. et al. Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study). Endoscopy 2018; 50: 961-971
  • 3 Spaander MC, Baron TH, Siersema PD. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016; 48: 939-948

Corresponding author

Noboru Kawata, MD
Division of Endoscopy
Shizuoka Cancer Center
1007 Shimonagakubo
Nagaizumi, Sunto-gun
Shizuoka 411-8777
Japan   

Publication History

Article published online:
16 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Spaander MCW, van der Bogt RD, Baron TH. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021. Endoscopy 2021; 53: 751-762
  • 2 Didden P, Reijm AN, Erler NS. et al. Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study). Endoscopy 2018; 50: 961-971
  • 3 Spaander MC, Baron TH, Siersema PD. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016; 48: 939-948

Zoom
Fig. 1 A fully covered self-expandable metal stent (Niti-S Stent 18 × 80 mm; Taewoong Medical, Seoul, Korea) was placed for malignant esophageal stenosis caused by advanced esophageal cancer.
Zoom
Fig. 2 Endoscopic images of esophageal bleeding after stent removal. Securement of the visual field and identification of the bleeding point were difficult due to the massive bleeding.
Zoom
Fig. 3 The balloon dilator was inflated to a pressure of 3 atm, and 3–5 minutes of direct compression hemostasis was repeated until confirmation of hemostasis.
Zoom
Fig. 4 Complete hemostasis was achieved after three session of direct compression hemostasis.